Early predictors of prolonged overall survival (OS) in patients (pts) on first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): An ARCAD study with individual patient data (IPD) on 10,962 pts.
Dirkje Willemien Sommeijer
No relevant relationships to disclose
Qian Shi
No relevant relationships to disclose
Everardo D. Saad
No relevant relationships to disclose
Elisabeth Coart
No relevant relationships to disclose
Marc E. Buyse
Employment or Leadership Position - IDDI
Stock Ownership - IDDI
Tomasz Burzykowski
No relevant relationships to disclose
Jeffrey P. Meyers
No relevant relationships to disclose
Tim Maughan
Consultant or Advisory Role - KGaA; Merck
Honoraria - KGaA; Merck
Richard A. Adams
No relevant relationships to disclose
Matthew T. Seymour
No relevant relationships to disclose
Leonard Saltz
No relevant relationships to disclose
Richard M. Goldberg
Consultant or Advisory Role - Bayer (U); Immunomedics (U); Lilly (U); Sanofi (U)
Honoraria - Biothera; Lilly; Sanofi
Research Funding - Bayer; Sanofi
Jean-Yves Douillard
No relevant relationships to disclose
Hans-Joachim Schmoll
No relevant relationships to disclose
Cornelis J. A. Punt
No relevant relationships to disclose
Christophe Tournigand
Consultant or Advisory Role - Amgen; Bayer; Merck; Roche; Sanofi
Honoraria - Amgen; Bayer; Merck; Roche; Sanofi
Research Funding - Roche; Sanofi
Benoist Chibaudel
No relevant relationships to disclose
Aimery De Gramont
No relevant relationships to disclose
Daniel J. Sargent
No relevant relationships to disclose
John Raymond Zalcberg
No relevant relationships to disclose